Biotech | August 05, 2021
Novavax signs agreement with European Commission for COVID19 vaccine
Deal for 100 million doses with additional 100 million through 2023
Deal for 100 million doses with additional 100 million through 2023
Innovative solutions and a deep understanding of the market makes this a unique combination
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
Robust demand for the product across the Middle East, Africa and Latin America
Complementary business models are the reason for the acquisition
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
Turnover of API division of ISLL stood at Rs 856.58 crore
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Subscribe To Our Newsletter & Stay Updated
